Bionano Genomics (BNGO) Other Working Capital Changes (2017 - 2026)

Bionano Genomics has disclosed Other Working Capital Changes across 10 years of filings, most recently posting -$339000.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$339000.0, down 358.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (up 306.31% YoY), and the FY2025 annual result was $2.1 million, up 230.26% from the prior year.
• Other Working Capital Changes came in at -$339000.0 for Q1 2026 at Bionano Genomics, down from -$173000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $6.4 million in Q4 2023 to a low of -$2.2 million in Q2 2023.
• The 5-year median for Other Working Capital Changes is -$74000.0 (2025), against an average of $491588.2.
• Peak annual rise in Other Working Capital Changes reached 3466.32% in 2023, while the deepest fall reached 5116.28% in 2023.
• Bionano Genomics' Other Working Capital Changes stood at -$190000.0 in 2022, then soared by 3466.32% to $6.4 million in 2023, then tumbled by 119.45% to -$1.2 million in 2024, then jumped by 86.09% to -$173000.0 in 2025, then tumbled by 95.95% to -$339000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$339000.0 (Q1 2026), -$173000.0 (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.